TRex Bio, Inc. (TRXB)
Trex Bio, Inc. engages in the manufacture of immunotherapies for autoimmune and inflammatory diseases. It focuses on studying the regulation of tissue inflammation to develop breakthrough medicines. The company was founded by Houman Ashrafian, Adil Daud, Wilson Liao, Diane Mathis, Drew Pardoll, Michael Rosenblum, Alison Simmons, and Jim Wells in May 24, 2018 and is headquartered in South San Francisco, CA.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Medical - Pharmaceuticals
TRex Bio Inc.
No financial data available.
No debt & equity data available.
No splits on record
Nothing in TRXB's public trading history: no forward or reverse split has affected the share count.
No balance sheet details available.
No income statement data available.
No balance sheet data available.
No cash flow data available.